27287100|t|Electrochemically assisted deposition of strontium modified magnesium phosphate on titanium surfaces
27287100|a|Electrochemically assisted deposition was utilized to produce ceramic coatings on the basis of magnesium ammonium phosphate (struvite) on corundum - blasted titanium surfaces. By the addition of defined concentrations of strontium nitrate to the coating electrolyte Sr(2+) ions were successfully incorporated into the struvite matrix. By variation of deposition parameters it was possible to fabricate coatings with different kinetics of Sr(2+) into physiological media, whereas the release of therapeutically relevant strontium doses could be sustained over several weeks. Morphological and crystallographic examinations of the immersed coatings revealed that the degradation of struvite and the release of Sr(2+) ions were accompanied by a transformation of the coating to a calcium phosphate based phase similar to low-crystalline hydroxyapatite. These findings showed that strontium doped struvite coatings may provide a promising degradable coating system for the local application of strontium or other biologically active metal ions in the implant-bone interface.
27287100	0	37	Electrochemically assisted deposition	T169	C0333562
27287100	41	50	strontium	T196	C0038467
27287100	60	79	magnesium phosphate	T121,T197	C0065527
27287100	83	91	titanium	T196	C0040302
27287100	92	100	surfaces	T082	C0205148
27287100	101	138	Electrochemically assisted deposition	T169	C0333562
27287100	163	170	ceramic	T073	C0007742
27287100	171	179	coatings	T080	C1522408
27287100	196	224	magnesium ammonium phosphate	T123,T197	C0126771
27287100	226	234	struvite	T123,T197	C0075338
27287100	239	247	corundum	T197	C0086065
27287100	250	257	blasted	T070	C0337026
27287100	258	266	titanium	T196	C0040302
27287100	267	275	surfaces	T082	C0205148
27287100	322	339	strontium nitrate	T121,T197	C0536786
27287100	347	354	coating	T080	C1522408
27287100	355	366	electrolyte	T121,T197	C0013832
27287100	367	378	Sr(2+) ions	T196	C0038467
27287100	397	409	incorporated	T169	C0243126
27287100	419	427	struvite	T123,T197	C0075338
27287100	428	434	matrix	T109,T121	C4050026
27287100	452	462	deposition	T169	C0333562
27287100	463	473	parameters	T077	C0549193
27287100	503	511	coatings	T080	C1522408
27287100	527	535	kinetics	T070	C0022702
27287100	539	545	Sr(2+)	T196	C0038467
27287100	595	610	therapeutically	T169	C0302350
27287100	611	619	relevant	T080	C2347946
27287100	620	629	strontium	T196	C0038467
27287100	630	635	doses	T081	C0178602
27287100	668	673	weeks	T079	C0439230
27287100	675	688	Morphological	T082	C0543482
27287100	693	722	crystallographic examinations	T059	C0022885
27287100	730	738	immersed	T080	C0205556
27287100	739	747	coatings	T080	C1522408
27287100	766	777	degradation	T169	C0243125
27287100	781	789	struvite	T123,T197	C0075338
27287100	798	805	release	T169	C0391871
27287100	809	820	Sr(2+) ions	T196	C0038467
27287100	843	857	transformation	T039	C3714584
27287100	865	872	coating	T080	C1522408
27287100	878	895	calcium phosphate	T121,T197	C0006711
27287100	919	949	low-crystalline hydroxyapatite	T197	C0020326
27287100	957	965	findings	T169	C2607943
27287100	978	987	strontium	T196	C0038467
27287100	994	1002	struvite	T123,T197	C0075338
27287100	1003	1011	coatings	T080	C1522408
27287100	1036	1046	degradable	T169	C0243125
27287100	1047	1054	coating	T080	C1522408
27287100	1055	1061	system	T169	C0449913
27287100	1091	1100	strontium	T196	C0038467
27287100	1110	1129	biologically active	T123	C0566267
27287100	1130	1140	metal ions	T197	C0025552
27287100	1148	1170	implant-bone interface	T030	C4042803